Prevention and Management Since SIBO often returns after treatment, long-term management is often necessary to focus on preventing recurrence and supporting digestive health
In other words, the darkening of the skin is a visible sign that damage has already occurred
However, resmetirom and semaglutide differ significantly in their mechanisms of action, metabolic effects, safety profiles, and potential clinical applications
Rely on peer-reviewed journals (NEJM, The Lancet, JAMA), official clinical trial registries (ClinicalTrials.gov), and communications from Eli Lilly
SELECT and FLOW both show favorable kidney effects from semaglutide